Amrutanjan Health Care Ltd

Amrutanjan Health Care Limited: Trading Window is closed from October 1, 2026 till the conclusion of 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ending September 30, 2026.

AGM details

• AGM held on 23 September 2026 at 10:30 AM via VC/OVAM.
• Record date: 11 September 2026.

Resolutions and outcomes

• Adoption of Audited Financial Statements for year ended 31 March 2026. Passed.
• Final dividend of Rs 2.90 per equity share. Passed.
• Re-appoint Ms. Ramaa Prabhakar Arikirevula as Non-Executive Director. Passed.
• Remuneration/appointment of Cost Auditors M/s Geyes & Co. for 2026-27. Passed.

Other governance / approvals

• No material related party transactions disclosed.
• No other material approvals reported.

AGM Details

• AGM held on 23 September 2026 at 10:30 AM via VC/OVAM.
• Quorum declared; e-voting provided; scrutinizer appointed.

Resolutions Put to Vote

• Adopt Audited Financial Statements for the year ended March 31, 2026.
• To declare final dividend for the year, subject to approval.
• To re-appoint Ms. Ramaa Prabhakar Arikirevula as Non-Executive Director.
• To approve remuneration of M/s Geeyes & Co., Cost Auditors for FY 2026-27.

Dividend Status

• Final dividend declared for the year; amount per share not disclosed.

Voting Results Status

• Voting results to be announced on the company's website within two working days.

Executive snapshot

• FY2025-26 revenue from operations ₹502.55 cr.
• Gross Sales ₹559.56 cr; FY25 ₹509.68 cr.
• PAT ₹57.92 cr; EPS ₹20.03.
• Net worth ₹370.23 cr; ROCE 21.40%.
• Interim dividends paid ₹5.78 cr; two instalments.
• Final dividend ₹12.90 per share; record date 11 Sep 2026.
• Sanitary napkin plant in Telangana to commence May 2027; capacity 700 mn.
• Board: 6 directors, 4 independent; Dr. Ramaswami Krishnan joined May 8, 2026.
• FY26 marketing focus: 44k new chemist outlets; 70% digitised processes.

Financial performance

• EBITDA ₹6,682.79 Lakhs; margin 13.30%.
• PBT ₹7,788.78 Lakhs; PAT ₹5,791.78 Lakhs.
• Total income ₹52,012.66 Lakhs; Revenue from operations ₹50,255.27 Lakhs.
• EPS (Basic) ₹20.03; Net cash from operations ₹3597.0 Lakhs.
• Interim dividends total ₹578.22 Lakhs; Final dividend ₹12.90 per share proposed.

Business mix and segments

• OTC Net Sales ₹32,831.73 Lakhs; WH ₹13,990.66 Lakhs; Beverages ₹3,156.09 Lakhs.
• Export revenue ₹11.15 Cr; Africa accounting for ~81% of exports.
• Comfy WH revenue ₹151.31 Cr; 18% YoY growth.
• FY25-26: Comfy Slimfit XXL Night Pads and Comfy Women’s Razors launched.
• Rural van initiatives expanded reach to ~1,000 villages.

Capex and manufacturing capacity

• Telangana Greenfield sanitary napkin plant ₹150 cr; 700 million annual capacity.
• Telangana plant to commence May FY2027; ~200 direct and 150 indirect jobs.
• New Allopathic OTC facility for export; compliant with cGMP.

Distribution and digital strategy

• FY2026: 44,000 new chemist outlets; target 100k by FY27.
• 68% of core processes automated; DMS/SAP TM rollout to ~85% by FY27.
• DMS implemented for 387 distributors; target 400 in FY27.
• Amazon USA/India e-commerce launches advancing digital footprint.

Corporate social responsibility

• CSR spend ₹129.18 Lakhs; focus education, health, animal welfare.
• CSR obligation under Section 135(5) ₹123.15 Lakhs; total spent ₹129.18.
• Multiple projects across education, health, environment; beneficiaries include IIMPACT, WildlifeSOS, SOS Village.

Governance and risks

• Board size six; four independent; Dr. Ramaswami Krishnan joined May 2026.
• Statutory and secretarial audits: unmodified report; UPSI data updates completed.
• No long-term debt; debt-to-equity ratio not applicable; net debt to equity 0.34.

Financial highlights

• FY2025-26 revenue from operations ₹5,025.5 cr; PAT ₹57.92 cr; EPS ₹20.03; EBITDA ₹66.83 cr.
• Interim dividends ₹2 per share; final dividend subject to AGM approval.

Capex & Expansion

• Telangana sanitary napkin plant: ₹150 crore capex, 700m annual capacity, commissioning May 2027.
• Two high-speed lines from Japan; 200 direct and 150 indirect jobs; cGMP facility.

Governance changes

• Dr. Ramaswami Krishnan appointed Independent Director w.e.f 8 May 2026.
• Raja Venkataraman ceased as Independent Director on 26 May 2026; G Raghavan retired 23 Sep 2025.

Shareholder & AGM updates

• 89th AGM on Sept 23, 2026 via VC/OAVM; record date Sept 11, 2026.
• Final dividend ₹12.90 per share proposed.

ESOP & CSR updates

• ESOP 2 withdrawn 17 Apr 2026; revised ESOP 2 approved 7–8 May 2026; unvested options converted.
• CSR outlay ₹12.92 cr; 2% of average net profit; FY2025-26 compliance.

Plant expansion

• Greenfield Telangana sanitary napkin plant commissioned; ₹150 crore investment, 10 acres, 1.4 lakh sq ft built-up.
• Fifth AHCL plant with two automated high-speed lines from Japan.

New launches and product mix

• Q4 FY26 launches include women's razors, men's razors, antiseptic plaster, ortho pain oil, nasal spray.
• New launches contributed 4% of AHCL sales in Q1 FY27.

Rent and exceptional item update

• Rent demand ₹974.67 lakhs paid on 1 Aug 2026; additional ₹202.75 lakhs provision booked.
• Previous year provision ₹760.50 lakhs; land possession handed over to Tamil Nadu government May 2018; one-time impact.

Operations and sales momentum

• Stockist up 7%, outlets up 17%, effective coverage up 8%, lines sold up 20% in Q1 FY27.
• Q1 FY27 net sales growth of 9.48%.

Outlook and commentary

• Outlook: double-digit revenue and operating profit growth; monetize Comfy Plant.
• War in West Asia pressures costs; price increases implemented to offset inflation.

Record date for final dividend

• Record date fixed as 11 September 2026 for payment of final dividend for FY 2025-26.

Key board decisions and disclosures

• Approved unaudited standalone results for quarter ended 30 June 2026, with Limited Review by BSR & Co. LLP.
• 89th AGM scheduled for 23 September 2026 via VC/OAVM.
• Record date for final dividend and voting eligibility fixed at 11 September 2026.
• Share transfer register closed from 12 to 23 September 2026.
• Segment rename: Women’s Hygiene to Women’s Hygiene & Personal Care.
• New Labour Codes: one-time employee benefits provision of INR 125.17 Lakhs recognised as exceptional item.
• Tamil Nadu lease rent revision: provision INR 760.50 Lakhs recognised; additional INR 202.75 Lakhs disclosed as exceptional item.
• Results filed with NSE and BSE and on company website.

Meeting Details

• Board meeting on 11 August 2026 to be held in Hyderabad.

Key Agenda Items

• Consider and approve unaudited financial results for quarter ended June 30, 2026 with Limited Review Report.

Other Notes

• Trading window closed from 1 July 2026 to 13 August 2026.